Looking into and preparing for the inevitable Plan G, and my health insurer just declined Rituxan, stating there was "not enough evidence" to support the treatment's use in MS. Hmm. This is virtually the same drug the FDA has fast tracked and is set to approve at the end of the year.

Comment